ITB News 24.80 07/01/2014 05:08:14 DJ US Home Construction Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DJ US Home Construction Ishares (ITB) 24.80 $ITB

Are Fears About the Housing Market Overblown? - Real Time Insight
Tracey Ryniec - Zacks Investment Research - Tue Jun 24, 1:00PM CDT
New home sales jump a surprising 16.9% for the best month since 2008.

'Fast Money' Recap: Muddling Along to Another All-Time High
at The Street - Sat Jun 21, 4:00AM CDT
The trading panel discussed the health of the U.S. consumer and which stocks to avoid for the summer.

Another Global Housing Crisis on the Horizon? - Real Time Insight
Neena Mishra - ZACKS - Wed Jun 11, 4:23PM CDT
Housing prices are going up sharply; should policy makers step in?

A Comprehensive Guide to Housing ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jun 09, 10:20AM CDT
Housing sector has been weak of late but can it rebound in coming months?

iShares U.S. Home Construction ETF (ITB) : Stop activated ($24.50)
Trading Central - Fri Jun 06, 10:28AM CDT
The stop loss which was set at $24.50 has been activated closing our short position opened on May 14th. Trading strategy: Stop activated ($24.50).

Has Spring Finally Sprung for Housing ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jun 02, 9:07AM CDT
Recent numbers suggest that the housing market may finally take off in the coming months.

Look for Shares of iShares Dow Jones US Homenstruction Index Fund to Potentially Pullback after Yesterday's 2.12% Rise
Comtex SmarTrend(R) - Fri May 23, 4:36PM CDT
iShares Dow Jones US Homenstruction Index Fund (NYSE:ITB) traded in a range yesterday that spanned from a low of $23.51 to a high of $24.05. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $23.62 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Time to Worry about Homebuilder ETFs? - ETF News And Commentary
Sweta Killa - ZACKS - Thu May 15, 12:00PM CDT
Given the sluggish fundamentals, investors should consider staying on the sidelines until the sector bottoms out.

iShares U.S. Home Construction ETF (ITB) : Short Sell @ $23.50
Trading Central - Wed May 14, 9:10AM CDT
From a technical view, the ETF has broken below a key rising trend line which has been in place since August 2013. Regarding technical indicators, the daily RSI is reversing down from its neutrality area which is acting as a resistance while the...

Jim Cramer's 'Mad Money' Recap: The Battle for the Market's Soul
at The Street - Tue May 06, 7:16PM CDT
For a moment, investors got a glimpse of the value they crave, Cramer says.

Jeff Gundlach Wants You to Short This Sector ETF - ETF News And Commentary
Eric Dutram - ZACKS - Tue May 06, 10:00AM CDT
According to Jeffrey Gundlach of DoubleLine Capital, pain could be ahead for this homebuilder ETF.

'Fast Money' Recap: Financial Sector Follies
at The Street - Tue May 06, 4:00AM CDT
The trading panel discussed which stocks have done well and which have not.

Homebuilder ETFs in Focus on Mixed-Bag Earnings - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 11:00AM CDT
Investors should watch these homebuilder ETFs for clues on to how the all important housing industry is performing.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 269

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 25

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 74

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 0

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 0

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
HONOR Leads in China, Eyes Middle East Market

Updated Category News Views 0

A Force to be Reckoned With Talk about making waves—HONOR's got the bragging rights now. Sitting pretty at the top among Android smartphone brands in China ain't no small feat. We're looking at a snazzy 12.04% market share for October 2026, all thanks to selling a cool 2.573 million units. The kicker? This ain't even their full potential. They're hustling hard in the...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 138

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 16

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 195

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 28

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading

Top 5 Most Recently Viewed Articles

GM Partners with Barclays to Enhance Credit Card Offerings

Updated Category News Views 71

General Motors and Barclays Sign a Strategic Partnership General Motors (NYSE: GM) and Barclays have recently announced a significant long-term partnership that focuses on credit card services. This strategic agreement reflects both companies' commitment to enhancing customer experience and providing innovative financial solutions. Benefits of the New Credit Card...

Continue Reading
Enbridge Inc. Declares 3% Increase in Quarterly Dividend

Updated Category News Views 126

Enbridge Inc. Increases Quarterly Dividend by 3% Enbridge Inc. (TSX: ENB) has made a significant announcement regarding its quarterly dividend. The company declared a quarterly dividend of $0.9425 per common share, signaling a 3% increase from previous rates. This notable hike reflects Enbridge's commitment to shareholder value and marks the thirtieth consecutive year of...

Continue Reading
Jefferies Advises Caution on Biotech-Related CRO Investments

Updated Category News Views 545

CROs Confront Challenges as Biotech Market Slows In a recent analysis, Jefferies is advising investors to rethink their investments in contract research organizations (CROs), particularly those focused on biotech and early-stage research. This caution comes as the demand in the biotech sector has noticeably declined. Financial Struggles Affects Companies Jefferies has...

Continue Reading
Remarkable Cost Savings with QUELIMMUNE for Pediatric AKI

Updated Category News Views 137

Significant Economic Impact of QUELIMMUNE Therapy SeaStar Medical Holding Corporation (Nasdaq: ICU), a pioneering healthcare company, has recently published a health economic analysis that underscores the substantial financial benefits of its QUELIMMUNE therapy for pediatric patients suffering from Acute Kidney Injury (AKI). The analysis highlights an estimated average...

Continue Reading
SKF Invites Fans to Revitalize Tattoos with Brand Update

Updated Category News Views 228

SKF Invites Fans to Revitalize Tattoos with Brand Update SKF has taken an impactful step to modernize its brand identity, showcasing a fresh and dynamic look aimed at connecting with its audience more effectively. This update marks the company's first significant change to its logo since its inception in 1908, highlighting the dedication to innovation while respecting its...

Continue Reading